Login here
Register Free
Webinars

Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond

Sponsored by: Labcorp
Speakers
Abstract
Watch the first of a three-part roundtable series that focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.
 
In this roundtable, the panel discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy. Specific areas of focus include:
  • Optimizing analytical test development and validation for dose analysis, molecular bioanalysis, transgene bioanalysis and immunogenicity, etc. 
  • Utilizing unique in vivo models requiring complex methods and routes of administration (e.g., intracranial, or ocular delivery, disease, or immunosuppressed models)
  • Driving cross-industry collaboration to support accelerating timelines and reducing risk
 
Watch roundtable 1: Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond 
Watch roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies 
Watch roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies
 
 
You May Also Like
DEC 10, 2024 | 9:00 AM
Expanding Proteomic Horizons with Single-Molecule Proteome Analysis
Expanding Proteomic Horizons with Single-Molecule Proteome Analysis
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Speaker: Parag Mallick, Ph.D.
Sponsored By: Nautilus Biotechnology
OCT 02, 2024 | 7:30 AM
Accelerate Discovery and Development by Optimizing the Protein Engineering Workflow
Accelerate Discovery and Development by Optimizing the Protein...
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Speaker: Claudia Chiocchini
Presented at: Cancer Research & Oncology Virtual Event Series 2024
Sponsored By: Thermo Fisher Scientific
Loading Comments...
Content Tags
See more
Attendees